Literature DB >> 7527477

Physiological concentrations of melatonin inhibit nitric oxide synthase in rat cerebellum.

D Pozo1, R J Reiter, J R Calvo, J M Guerrero.   

Abstract

In the present paper we show the inhibitory effect of melatonin on rat cerebellar nitric oxide synthase (NOS) activity. NO production was monitored by the stoichiometric conversion of L-arginine to L-citrulline. The inhibitory effect of melatonin was dose-dependent, with an IC50 value of about 0.1 mM. However, a significant inhibition of enzyme activity (> 22%) was observed at 1 nM melatonin which is in the range of the physiological serum concentration of the hormone at night. The inhibitory effect of melatonin was observed exclusively in the presence of Ca++. Results suggest a new and important role of the pineal hormone melatonin on central nervous system processes, i.e., by modulating NO production.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7527477     DOI: 10.1016/0024-3205(94)00532-x

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  21 in total

1.  Neuroprotective and neurorestorative strategies for neuronal injury.

Authors:  M F Beal; T Palomo; R M Kostrzewa; T Archer
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

Review 2.  Melatonin and nitric oxide.

Authors:  S Aydogan; M Betul Yerer; A Goktas
Journal:  J Endocrinol Invest       Date:  2006-03       Impact factor: 4.256

3.  In vitro stimulation of protein kinase C by melatonin.

Authors:  F Antón-Tay; G Ramírez; I Martínez; G Benítez-King
Journal:  Neurochem Res       Date:  1998-05       Impact factor: 3.996

Review 4.  Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance.

Authors:  Rüdiger Hardeland
Journal:  Endocrine       Date:  2005-07       Impact factor: 3.633

5.  Melatonin prevents ethanol-induced gastric mucosal damage possibly due to its antioxidant effect.

Authors:  Dilek Bilici; Halis Süleyman; Z Nur Banoğlu; Ahmet Kiziltunç; Bahattin Avci; Akif Ciftçioğlu; Sefa Bilici
Journal:  Dig Dis Sci       Date:  2002-04       Impact factor: 3.199

6.  Melatonin reduces the increase in 8-hydroxy-deoxyguanosine levels in the brain and liver of kainic acid-treated rats.

Authors:  L Tang; R J Reiter; Z R Li; G G Ortiz; B P Yu; J J Garcia
Journal:  Mol Cell Biochem       Date:  1998-01       Impact factor: 3.396

Review 7.  The melatonin immunomodulatory actions in radiotherapy.

Authors:  M Najafi; A Shirazi; E Motevaseli; Gh Geraily; F Norouzi; M Heidari; S Rezapoor
Journal:  Biophys Rev       Date:  2017-03-27

Review 8.  Melatonin and Multiple Sclerosis: From Plausible Neuropharmacological Mechanisms of Action to Experimental and Clinical Evidence.

Authors:  Mahshid Yeganeh Salehpour; Adriano Mollica; Saeideh Momtaz; Nima Sanadgol; Mohammad Hosein Farzaei
Journal:  Clin Drug Investig       Date:  2019-07       Impact factor: 2.859

Review 9.  Development of nitric oxide synthase inhibitors for neurodegeneration and neuropathic pain.

Authors:  Paramita Mukherjee; Maris A Cinelli; Soosung Kang; Richard B Silverman
Journal:  Chem Soc Rev       Date:  2014-10-07       Impact factor: 54.564

10.  Inflammatory status and kynurenine metabolism in rheumatoid arthritis treated with melatonin.

Authors:  Caroline M Forrest; Gillian M Mackay; Nicholas Stoy; Trevor W Stone; L Gail Darlington
Journal:  Br J Clin Pharmacol       Date:  2007-05-15       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.